BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15070402)

  • 1. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
    Berti C; Fontanella B; Ferrentino R; Meroni G
    BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.
    Short KM; Hopwood B; Yi Z; Cox TC
    BMC Cell Biol; 2002; 3():1. PubMed ID: 11806752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FXY2/MID2, a gene related to the X-linked Opitz syndrome gene FXY/MID1, maps to Xq22 and encodes a FNIII domain-containing protein that associates with microtubules.
    Perry J; Short KM; Romer JT; Swift S; Cox TC; Ashworth A
    Genomics; 1999 Dec; 62(3):385-94. PubMed ID: 10644436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Opitz syndrome gene product, MID1, associates with microtubules.
    Schweiger S; Foerster J; Lehmann T; Suckow V; Muller YA; Walter G; Davies T; Porter H; van Bokhoven H; Lunt PW; Traub P; Ropers HH
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2794-9. PubMed ID: 10077590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex.
    Aranda-Orgillés B; Trockenbacher A; Winter J; Aigner J; Köhler A; Jastrzebska E; Stahl J; Müller EC; Otto A; Wanker EE; Schneider R; Schweiger S
    Hum Genet; 2008 Mar; 123(2):163-76. PubMed ID: 18172692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
    Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
    PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structure-function study of MID1 mutations associated with a mild Opitz phenotype.
    Mnayer L; Khuri S; Merheby HA; Meroni G; Elsas LJ
    Mol Genet Metab; 2006 Mar; 87(3):198-203. PubMed ID: 16378742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.
    Liu J; Prickett TD; Elliott E; Meroni G; Brautigan DL
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6650-5. PubMed ID: 11371618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development.
    Buchner G; Montini E; Andolfi G; Quaderi N; Cainarca S; Messali S; Bassi MT; Ballabio A; Meroni G; Franco B
    Hum Mol Genet; 1999 Aug; 8(8):1397-407. PubMed ID: 10400986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the microtubule-targeting COS domain of MID1.
    Wright KM; Du H; Dagnachew M; Massiah MA
    FEBS J; 2016 Aug; 283(16):3089-102. PubMed ID: 27367845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.
    Du H; Wu K; Didoronkute A; Levy MV; Todi N; Shchelokova A; Massiah MA
    PLoS One; 2014; 9(9):e107428. PubMed ID: 25207814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E3 ubiquitin ligase MID1/TRIM18 promotes atypical ubiquitination of the BRCA2-associated factor 35, BRAF35.
    Zanchetta ME; Napolitano LMR; Maddalo D; Meroni G
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1844-1854. PubMed ID: 28760657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.
    Trockenbacher A; Suckow V; Foerster J; Winter J; Krauss S; Ropers HH; Schneider R; Schweiger S
    Nat Genet; 2001 Nov; 29(3):287-94. PubMed ID: 11685209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional observations of the P151L MID1 mutation reveal alpha4 plays a significant role in X-linked Opitz Syndrome.
    Wright KM; Du H; Massiah MA
    FEBS J; 2017 Jul; 284(14):2183-2193. PubMed ID: 28548391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
    Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle.
    Cainarca S; Messali S; Ballabio A; Meroni G
    Hum Mol Genet; 1999 Aug; 8(8):1387-96. PubMed ID: 10400985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).
    Aranda-Orgillés B; Rutschow D; Zeller R; Karagiannidis AI; Köhler A; Chen C; Wilson T; Krause S; Roepcke S; Lilley D; Schneider R; Schweiger S
    J Biol Chem; 2011 Nov; 286(46):39945-57. PubMed ID: 21930711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental expression of alpha4 protein phosphatase regulatory subunit in tissues affected by Opitz syndrome.
    Everett AD; Brautigan DL
    Dev Dyn; 2002 Aug; 224(4):461-4. PubMed ID: 12203739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of functional redundancy between MID proteins: implications for the presentation of Opitz syndrome.
    Granata A; Savery D; Hazan J; Cheung BM; Lumsden A; Quaderi NA
    Dev Biol; 2005 Jan; 277(2):417-24. PubMed ID: 15617684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations.
    So J; Suckow V; Kijas Z; Kalscheuer V; Moser B; Winter J; Baars M; Firth H; Lunt P; Hamel B; Meinecke P; Moraine C; Odent S; Schinzel A; van der Smagt JJ; Devriendt K; Albrecht B; Gillessen-Kaesbach G; van der Burgt I; Petrij F; Faivre L; McGaughran J; McKenzie F; Opitz JM; Cox T; Schweiger S
    Am J Med Genet A; 2005 Jan; 132A(1):1-7. PubMed ID: 15558842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.